474 related articles for article (PubMed ID: 9458709)
1. ATP-sensitive K+ channels in pancreatic, cardiac, and vascular smooth muscle cells.
Yokoshiki H; Sunagawa M; Seki T; Sperelakis N
Am J Physiol; 1998 Jan; 274(1):C25-37. PubMed ID: 9458709
[TBL] [Abstract][Full Text] [Related]
2. Potassium channel openers require ATP to bind to and act through sulfonylurea receptors.
Schwanstecher M; Sieverding C; Dörschner H; Gross I; Aguilar-Bryan L; Schwanstecher C; Bryan J
EMBO J; 1998 Oct; 17(19):5529-35. PubMed ID: 9755153
[TBL] [Abstract][Full Text] [Related]
3. Molecular biology of adenosine triphosphate-sensitive potassium channels.
Aguilar-Bryan L; Bryan J
Endocr Rev; 1999 Apr; 20(2):101-35. PubMed ID: 10204114
[TBL] [Abstract][Full Text] [Related]
4. Different molecular sites of action for the KATP channel inhibitors, PNU-99963 and PNU-37883A.
Cui Y; Tinker A; Clapp LH
Br J Pharmacol; 2003 May; 139(1):122-8. PubMed ID: 12746230
[TBL] [Abstract][Full Text] [Related]
5. Effect of repaglinide on cloned beta cell, cardiac and smooth muscle types of ATP-sensitive potassium channels.
Dabrowski M; Wahl P; Holmes WE; Ashcroft FM
Diabetologia; 2001 Jun; 44(6):747-56. PubMed ID: 11440368
[TBL] [Abstract][Full Text] [Related]
6. Syntaxin-1A inhibits cardiac KATP channels by its actions on nucleotide binding folds 1 and 2 of sulfonylurea receptor 2A.
Kang Y; Leung YM; Manning-Fox JE; Xia F; Xie H; Sheu L; Tsushima RG; Light PE; Gaisano HY
J Biol Chem; 2004 Nov; 279(45):47125-31. PubMed ID: 15339904
[TBL] [Abstract][Full Text] [Related]
7. Role of the C-terminus of SUR in the differential regulation of β-cell and cardiac K
Vedovato N; Rorsman O; Hennis K; Ashcroft FM; Proks P
J Physiol; 2018 Dec; 596(24):6205-6217. PubMed ID: 30179258
[TBL] [Abstract][Full Text] [Related]
8. Stoichiometry of sulfonylurea-induced ATP-sensitive potassium channel closure.
Dörschner H; Brekardin E; Uhde I; Schwanstecher C; Schwanstecher M
Mol Pharmacol; 1999 Jun; 55(6):1060-6. PubMed ID: 10347249
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity of KATP channels to cellular metabolic disorders and the underlying structural basis.
Li CG; Cui WY; Wang H
Acta Pharmacol Sin; 2016 Jan; 37(1):134-42. PubMed ID: 26725741
[TBL] [Abstract][Full Text] [Related]
10. Effects of ZD0947, a novel and potent ATP-sensitive K
Mori K; Yamashita Y; Teramoto N
Eur J Pharmacol; 2016 Nov; 791():773-779. PubMed ID: 27693800
[TBL] [Abstract][Full Text] [Related]
11. Nateglinide, a D-phenylalanine derivative lacking either a sulfonylurea or benzamido moiety, specifically inhibits pancreatic beta-cell-type K(ATP) channels.
Chachin M; Yamada M; Fujita A; Matsuoka T; Matsushita K; Kurachi Y
J Pharmacol Exp Ther; 2003 Mar; 304(3):1025-32. PubMed ID: 12604678
[TBL] [Abstract][Full Text] [Related]
12. Different binding properties and affinities for ATP and ADP among sulfonylurea receptor subtypes, SUR1, SUR2A, and SUR2B.
Matsuo M; Tanabe K; Kioka N; Amachi T; Ueda K
J Biol Chem; 2000 Sep; 275(37):28757-63. PubMed ID: 10893240
[TBL] [Abstract][Full Text] [Related]
13. Effects of mitiglinide (S 21403) on Kir6.2/SUR1, Kir6.2/SUR2A and Kir6.2/SUR2B types of ATP-sensitive potassium channel.
Reimann F; Proks P; Ashcroft FM
Br J Pharmacol; 2001 Apr; 132(7):1542-8. PubMed ID: 11264248
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis and characteristics of KATP channel in human corporal smooth muscle cells.
Insuk SO; Chae MR; Choi JW; Yang DK; Sim JH; Lee SW
Int J Impot Res; 2003 Aug; 15(4):258-66. PubMed ID: 12934053
[TBL] [Abstract][Full Text] [Related]
15. A view of sur/KIR6.X, KATP channels.
Babenko AP; Aguilar-Bryan L; Bryan J
Annu Rev Physiol; 1998; 60():667-87. PubMed ID: 9558481
[TBL] [Abstract][Full Text] [Related]
16. Differential response of K(ATP) channels containing SUR2A or SUR2B subunits to nucleotides and pinacidil.
Reimann F; Gribble FM; Ashcroft FM
Mol Pharmacol; 2000 Dec; 58(6):1318-25. PubMed ID: 11093769
[TBL] [Abstract][Full Text] [Related]
17. Differential nucleotide regulation of KATP channels by SUR1 and SUR2A.
Masia R; Enkvetchakul D; Nichols CG
J Mol Cell Cardiol; 2005 Sep; 39(3):491-501. PubMed ID: 15893323
[TBL] [Abstract][Full Text] [Related]
18. Phenylephrine preconditioning in embryonic heart H9c2 cells is mediated by up-regulation of SUR2B/Kir6.2: A first evidence for functional role of SUR2B in sarcolemmal KATP channels and cardioprotection.
Jovanović S; Ballantyne T; Du Q; Blagojević M; Jovanović A
Int J Biochem Cell Biol; 2016 Jan; 70():23-8. PubMed ID: 26556311
[TBL] [Abstract][Full Text] [Related]
19. Interaction of a novel dihydropyridine K+ channel opener, A-312110, with recombinant sulphonylurea receptors and KATP channels: comparison with the cyanoguanidine P1075.
Felsch H; Lange U; Hambrock A; Löffler-Walz C; Russ U; Carroll WA; Gopalakrishnan M; Quast U
Br J Pharmacol; 2004 Apr; 141(7):1098-105. PubMed ID: 15023854
[TBL] [Abstract][Full Text] [Related]
20. Sulfonylureas suppress the stimulatory action of Mg-nucleotides on Kir6.2/SUR1 but not Kir6.2/SUR2A KATP channels: a mechanistic study.
Proks P; de Wet H; Ashcroft FM
J Gen Physiol; 2014 Nov; 144(5):469-86. PubMed ID: 25348414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
